Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
My Bing
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
Trending on Bing
Final Astroworld suit settled
At least 100 killed in landslide
'This means war'
'Doge' meme dog dies
US issues visa restrictions
Signs new abortion bill
Duggan can be extradited
Wash. wind farm proposal
2022 Osprey crash lawsuit
Arrested, charged w/ fraud
Planet parade 2024
First teaser revealed
Gets Walk of Fame star
Support AIDS research
Pistons new president?
Bong's plane discovered?
To hold output policy meeting
Planet that could support life
US service members injured
Priest bites woman?
Daytime Emmy Awards hosts
Wins Idaho caucuses
Judge revisits immigration law
Drops ‘Dark Times' album
2 shot at graduation event
Ala. coal ash plan rejected
Official images of B21 Raider
AI deals with Hollywood?
China's 2nd day of war games
CIA director to visit Europe
Approves ETFs for Ether
OH gov. calls special session
Lovett joins ‘Survivor’ cast
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Novavax, Sanofi
Novavax Stock More Than Doubles After Sanofi Vaccine-Licensing Deal
Novavax shares (NVAX) surged after the vaccine maker said it had struck a licensing deal worth up to $1.4 billion with Sanofi (SNY, FR:SAN). Novavax sha
Novavax Shares Surge Over 130% After $1.4 Billion Covid Shot Deal With Sanofi
The biotech company said it would develop a combination Covid and flu shot with Sanofi as part of a billion-dollar deal.
Novavax top investor ends proxy fight after Sanofi deal
Novavax (NVAX) stock as Shah Capital withdraws its proxy campaign against the company following a licensing agreement with Sanofi (SNY). Read more here.
Benefits Pro
11d
Novavax strikes $1.2B deal with Sanofi to develop COVID-flu combo vaccine
With flu and COVID hospital admission rates now mirroring each other,
Novavax
, which lost out in the COVID
vaccine
race ...
4d
on MSN
Shah Capital ends campaign against Novavax board after Sanofi deal
Hedge fund Shah Capital said on Monday it would withdraw its campaign against the re-election of three directors on Novavax's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback